Task: Answer the multiple-choice question.
Query: Which drug has a 0.411\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CC(=O)Nc1cccc(NC(=O)Nc2ccc(C)c(Cl)c2)c1
b CC(C)Cc1nc2oc3c(=O)[nH]cnc3c2c2c1CCC2
c COc1ccc(C(C)NC(=O)Cc2cccs2)cc1
Answer: b. CC(C)Cc1nc2oc3c(=O)[nH]cnc3c2c2c1CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Cc1nc2oc3c(=O)[nH]cnc3c2c2c1CCC2
CC(C)Cc1nc2oc3c(=O)[nH]cnc3c2c2c1CCC2
7-(2-methylpropyl)-10-oxa-8,13,15-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),2(6),7,11(16),14-pentaen-12-one